The European Court of First Instance partially annulled the European Commission's decision finding the existence of cartels and an abuse of a dominant position on the market for perindopril, a medicine to combat heart problems, in several judgements delivered on Wednesday 12 December (Cases T-677, 679, 680, 682, 684, 691, 701, 705/14).
Following disputes over the validity of the 947 patent for erbumine, the active pharmaceutical ingredient of perindopril, the French Servier group has...